Wilmington, DE -- (SBWIRE) -- 02/03/2014 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding RF Micro Devices Inc. (NASDAQ:RFMD) and Mylan, Inc. (NASDAQ:MYL).
RF Micro Devices Inc. (NASDAQ:RFMD) a company that engages in the design, development, manufacture, and marketing of radio frequency solutions for original equipment manufacturers and original design manufacturers in wireless and wired communications applications in the United States and internationally is currently down (-2.91%) on 5,978,068 shares traded. RF Micro Devices Inc. (NASDAQ:RFMD) is currently down (-16.77%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.
Click Here to find out what other Investors are saying about RF Micro Devices Inc. (NASDAQ:RFMD)
Mylan, Inc. (NASDAQ:MYL) a company that engages in the development, manufacture, marketing, licensing, and distribution of generic and branded generic pharmaceuticals, specialty pharmaceuticals, and active pharmaceutical ingredients worldwide is currently down (-3.94%) on 3,414,048 shares traded after Mylan Labs launched first Trastuzumab Biosimilar, Hertraz, in India. Mylan, Inc. (NASDAQ:MYL) is currently down (-6.93%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.
Click Here to find out what other Investors are saying about Mylan, Inc. (NASDAQ:MYL)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)